List of Tables
Table 1. Global VLP Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global VLP Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global VLP Vaccines Market Competitive Situation by Manufacturers in 2023
Table 4. Global VLP Vaccines Sales (K Doses) of Key Manufacturers (2019-2024)
Table 5. Global VLP Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 6. Global VLP Vaccines Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global VLP Vaccines Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market VLP Vaccines Average Price (US$/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of VLP Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of VLP Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of VLP Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of VLP Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global VLP Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in VLP Vaccines as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global VLP Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global VLP Vaccines Sales by Region (2019-2024) & (K Doses)
Table 18. Global VLP Vaccines Sales Market Share by Region (2019-2024)
Table 19. Global VLP Vaccines Sales by Region (2025-2030) & (K Doses)
Table 20. Global VLP Vaccines Sales Market Share by Region (2025-2030)
Table 21. Global VLP Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global VLP Vaccines Revenue Market Share by Region (2019-2024)
Table 23. Global VLP Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global VLP Vaccines Revenue Market Share by Region (2025-2030)
Table 25. North America VLP Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America VLP Vaccines Sales by Country (2019-2024) & (K Doses)
Table 27. North America VLP Vaccines Sales by Country (2025-2030) & (K Doses)
Table 28. North America VLP Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America VLP Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe VLP Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe VLP Vaccines Sales by Country (2019-2024) & (K Doses)
Table 32. Europe VLP Vaccines Sales by Country (2025-2030) & (K Doses)
Table 33. Europe VLP Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe VLP Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific VLP Vaccines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific VLP Vaccines Sales by Region (2019-2024) & (K Doses)
Table 37. Asia Pacific VLP Vaccines Sales by Region (2025-2030) & (K Doses)
Table 38. Asia Pacific VLP Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific VLP Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America VLP Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America VLP Vaccines Sales by Country (2019-2024) & (K Doses)
Table 42. Latin America VLP Vaccines Sales by Country (2025-2030) & (K Doses)
Table 43. Latin America VLP Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America VLP Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa VLP Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa VLP Vaccines Sales by Country (2019-2024) & (K Doses)
Table 47. Middle East & Africa VLP Vaccines Sales by Country (2025-2030) & (K Doses)
Table 48. Middle East & Africa VLP Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa VLP Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global VLP Vaccines Sales (K Doses) by Type (2019-2024)
Table 51. Global VLP Vaccines Sales (K Doses) by Type (2025-2030)
Table 52. Global VLP Vaccines Sales Market Share by Type (2019-2024)
Table 53. Global VLP Vaccines Sales Market Share by Type (2025-2030)
Table 54. Global VLP Vaccines Revenue (US$ Million) by Type (2019-2024)
Table 55. Global VLP Vaccines Revenue (US$ Million) by Type (2025-2030)
Table 56. Global VLP Vaccines Revenue Market Share by Type (2019-2024)
Table 57. Global VLP Vaccines Revenue Market Share by Type (2025-2030)
Table 58. Global VLP Vaccines Price (US$/Dose) by Type (2019-2024)
Table 59. Global VLP Vaccines Price (US$/Dose) by Type (2025-2030)
Table 60. Global VLP Vaccines Sales (K Doses) by Application (2019-2024)
Table 61. Global VLP Vaccines Sales (K Doses) by Application (2025-2030)
Table 62. Global VLP Vaccines Sales Market Share by Application (2019-2024)
Table 63. Global VLP Vaccines Sales Market Share by Application (2025-2030)
Table 64. Global VLP Vaccines Revenue (US$ Million) by Application (2019-2024)
Table 65. Global VLP Vaccines Revenue (US$ Million) by Application (2025-2030)
Table 66. Global VLP Vaccines Revenue Market Share by Application (2019-2024)
Table 67. Global VLP Vaccines Revenue Market Share by Application (2025-2030)
Table 68. Global VLP Vaccines Price (US$/Dose) by Application (2019-2024)
Table 69. Global VLP Vaccines Price (US$/Dose) by Application (2025-2030)
Table 70. Medicago Corporation Information
Table 71. Medicago Description and Business Overview
Table 72. Medicago VLP Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 73. Medicago VLP Vaccines Product
Table 74. Medicago Recent Developments/Updates
Table 75. Novavax Corporation Information
Table 76. Novavax Description and Business Overview
Table 77. Novavax VLP Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 78. Novavax VLP Vaccines Product
Table 79. Novavax Recent Developments/Updates
Table 80. Saiba Animal Health Corporation Information
Table 81. Saiba Animal Health Description and Business Overview
Table 82. Saiba Animal Health VLP Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 83. Saiba Animal Health VLP Vaccines Product
Table 84. Saiba Animal Health Recent Developments/Updates
Table 85. VBI Corporation Information
Table 86. VBI Description and Business Overview
Table 87. VBI VLP Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 88. VBI VLP Vaccines Product
Table 89. VBI Recent Developments/Updates
Table 90. ARTES Biotechnology Corporation Information
Table 91. ARTES Biotechnology Description and Business Overview
Table 92. ARTES Biotechnology VLP Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 93. ARTES Biotechnology VLP Vaccines Product
Table 94. ARTES Biotechnology Recent Developments/Updates
Table 95. VLP Therapeutics Corporation Information
Table 96. VLP Therapeutics Description and Business Overview
Table 97. VLP Therapeutics VLP Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 98. VLP Therapeutics VLP Vaccines Product
Table 99. VLP Therapeutics Recent Developments/Updates
Table 100. POSVAX Corporation Information
Table 101. POSVAX Description and Business Overview
Table 102. POSVAX VLP Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 103. POSVAX VLP Vaccines Product
Table 104. POSVAX Recent Developments/Updates
Table 105. Spybiotech Corporation Information
Table 106. Spybiotech Description and Business Overview
Table 107. Spybiotech VLP Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 108. Spybiotech VLP Vaccines Product
Table 109. Spybiotech Recent Developments/Updates
Table 110. Optipharm Co. Ltd Corporation Information
Table 111. Optipharm Co. Ltd Description and Business Overview
Table 112. Optipharm Co. Ltd VLP Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 113. Optipharm Co. Ltd VLP Vaccines Product
Table 114. Optipharm Co. Ltd Recent Developments/Updates
Table 115. H&Z Life Science Corporation Information
Table 116. H&Z Life Science Description and Business Overview
Table 117. H&Z Life Science VLP Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 118. H&Z Life Science VLP Vaccines Product
Table 119. H&Z Life Science Recent Developments/Updates
Table 120. Gproan Corporation Information
Table 121. Gproan Description and Business Overview
Table 122. Gproan VLP Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 123. Gproan VLP Vaccines Product
Table 124. Gproan Recent Developments/Updates
Table 125. Merck Corporation Information
Table 126. Merck Description and Business Overview
Table 127. Merck VLP Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 128. Merck VLP Vaccines Product
Table 129. Merck Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. VLP Vaccines Distributors List
Table 133. VLP Vaccines Customers List
Table 134. VLP Vaccines Market Trends
Table 135. VLP Vaccines Market Drivers
Table 136. VLP Vaccines Market Challenges
Table 137. VLP Vaccines Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of VLP Vaccines
Figure 2. Global VLP Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global VLP Vaccines Market Share by Type in 2023 & 2030
Figure 4. HPV Vaccine Product Picture
Figure 5. Covid-19 Vaccine Product Picture
Figure 6. Hepatitis B Vaccine Product Picture
Figure 7. Others Product Picture
Figure 8. Global VLP Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global VLP Vaccines Market Share by Application in 2023 & 2030
Figure 10. Government
Figure 11. Medical Institution
Figure 12. Others
Figure 13. Global VLP Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global VLP Vaccines Market Size (2019-2030) & (US$ Million)
Figure 15. Global VLP Vaccines Sales (2019-2030) & (K Doses)
Figure 16. Global VLP Vaccines Average Price (US$/Dose) & (2019-2030)
Figure 17. VLP Vaccines Report Years Considered
Figure 18. VLP Vaccines Sales Share by Manufacturers in 2023
Figure 19. Global VLP Vaccines Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest VLP Vaccines Players: Market Share by Revenue in 2023
Figure 21. VLP Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global VLP Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America VLP Vaccines Sales Market Share by Country (2019-2030)
Figure 24. North America VLP Vaccines Revenue Market Share by Country (2019-2030)
Figure 25. United States VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe VLP Vaccines Sales Market Share by Country (2019-2030)
Figure 28. Europe VLP Vaccines Revenue Market Share by Country (2019-2030)
Figure 29. Germany VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific VLP Vaccines Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific VLP Vaccines Revenue Market Share by Region (2019-2030)
Figure 36. China VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America VLP Vaccines Sales Market Share by Country (2019-2030)
Figure 46. Latin America VLP Vaccines Revenue Market Share by Country (2019-2030)
Figure 47. Mexico VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa VLP Vaccines Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa VLP Vaccines Revenue Market Share by Country (2019-2030)
Figure 52. Turkey VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE VLP Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of VLP Vaccines by Type (2019-2030)
Figure 56. Global Revenue Market Share of VLP Vaccines by Type (2019-2030)
Figure 57. Global VLP Vaccines Price (US$/Dose) by Type (2019-2030)
Figure 58. Global Sales Market Share of VLP Vaccines by Application (2019-2030)
Figure 59. Global Revenue Market Share of VLP Vaccines by Application (2019-2030)
Figure 60. Global VLP Vaccines Price (US$/Dose) by Application (2019-2030)
Figure 61. VLP Vaccines Value Chain
Figure 62. VLP Vaccines Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed